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I
t is generally accepted that multiple factors play a role in
gastric carcinogenesis, including diet,1 2 lifestyle,3 infectious
agents such as Helicobacter pylori (H. pylori),4 5 and genetic
factors as well as gene-environment interactions.6 7 Although
the continuous decrease in the incidence of gastric cancer in
recent decades can be explained by changing lifestyle, diet
habits, and reduced H. pylori infection, the fact that some
individuals develop gastric cancer while others do not under
similar environmental exposures suggests that genetic pre-
disposition plays an important role in the pathogenesis of this
disease. In addition, familial clustering of cases of gastric
cancer, a higher incidence of the disease among the relatives
of patients than among matched controls, and a more
common coincidence of the disease in homozygotic than in
heterozygotic twins, also supports genetic links with gastric
cancer.8–10
In contrast with the vast amount of accumulated informa-
tion on environmental factors, little is known about the
genetic factors linked to gastric cancer. Several studies have
reported disease susceptible loci for gastric cancer, based on
association analysis of candidate genes involved in DNA
repair, detoxification, or the immune system.11 Studies on
familial clustering of gastric cancer revealed germline
mutations in CDH1, ATM, and MET.12–14 In addition, gastric
cancer frequently occurs in family members with monogenic
diseases such as hereditary non-polyposis colorectal cancer,
Li-Fraumeni syndrome, familial adenomatous polyposis, and
Peutz-Jeghers syndrome.15–18 However, these polymorphisms
and/or mutations cannot explain the overall genetic compo-
nents of gastric cancer.
It is now feasible to screen the entire human genome for
genes exerting a major effect on susceptibility to multi-
factorial diseases. Because gastric cancer, like many complex
diseases, exhibits genetic heterogeneity, we carried out a
genome-wide linkage study to search for possible suscept-
ibility loci related to gastric cancer, using a non-parametric
sibpair method in 170 affected sibpairs from 142 Japanese
families. The data we obtained yielded chromosomal regions




A total of 297 gastric cancer patients, including 170
informative sibpairs, from 142 Japanese families were
recruited with the approval of the Ethical Committee of
Kyushu University, Fukuoka, Japan. Nine of the families
included three affected sibs and two included four affected
sibs. The mean age at diagnosis of these 297 patients was
57.0 years and the male to female ratio was 1.69. All
participants provided written informed consent. The diag-
nosis of gastric cancer was confirmed by pathological records
and/or by examination of medical records at hospitals where
the patients were surgically treated.
Genotyping
Genotyping was carried out as described.19 Briefly, genomic
DNA was extracted from total peripheral blood using
QIAamp DNA Blood Mid Kits (Qiagen, Valencia, CA, USA).
ABI PRISM Linkage Mapping Set Version 2 (Applied
Biosystems, Foster City, CA, USA) was used for amplification
of 392 microsatellite markers spanning the entire human
genome with an average interval of 10 cM. PCR reaction was
carried out in a 15 ml volume using reagent concentrations
and temperature profiles as recommended by the manufac-
ture (Applied Biosystems). Amplification of the expected size
of double strand DNA was confirmed by agarose gel
electrophoresis. The fluorescence labelled PCR products were
pooled (10–20 markers/pool) and electrophoresis was carried
out using the ABI PRISM model 377 or 3100 DNA sequencer
equipped with Genescan software (Applied Biosystems) for
Key points
N We carried out a genome-wide screen to search for
regions of the human genome containing gastric
cancer susceptibility genes in 170 affected sibpairs
from 142 Japanese families, using 392 microsatellite
markers spanning the entire genome.
N Non-parametric linkage analysis of the entire data set,
using the MAPMAKER/SIBS program, identified four
regions, 1p32, 2q33–q35, 11p13–p14, and 21q21,
showing evidence for linkage with a multipoint
logarithm of odds (LOD) score of >1.18 (p(0.01).
The strongest signal was observed on chromosome
2q33–35 (multipoint and two point LOD scores of 1.74
and 1.98, respectively).
N In an analysis of a subgroup with proximal gastric
cancer, the signal of linkage to 2q33–q35 increased
to multipoint and two point LOD scores of 3.61 and
2.93, respectively. Simulation studies revealed that
this finding exceeded that expected by chance
(p = 0.002). Furthermore, a linkage signal to chromo-
some 2q33–35 was confirmed by additional markers
and the MERLIN program (multipoint LOD scores of
3.38 and 2.66, respectively). Our results suggest the
presence of a gastric cancer susceptibility locus on this
chromosome.
Abbreviations: LOD, logarithm of odds
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genotyping. The marker alleles were visualised using
Genotyper software (Applied Biosystems).
Statistical analysis
Multipoint or two point analysis for logarithm of odds (LOD)
scores was carried out on all possible weighted 170 pairs,
using the MAPMAKER/SIBS or MERLIN program.
Multipoint LOD scores >1.18 (p(0.01) were identified as
nominal evidence for linkage, LOD scores >2.2 as suggestive
(p(0.0007), and LOD scores >3.6 as significant
(p(0.00002).20
For a chromosomal locus showing the highest multipoint
LOD score, simulation studies were carried out to evaluate a
genome-wide significance of linkage using the MERLIN
program which generates simulated chromosomes condi-
tional on family structure, actual marker spacings, and allele
frequencies, as well as missing data patterns.21
Subgroups stratification
Since numerous reports indicate different etiologies in
subsites or histological subtypes,3 7 22 23 linkage analyses were
carried out for subgroups stratified on tumour localisation
and histology. As it can be assumed that a sibpair shares the
same genetic factors involved in gastric cancer, subgroups
included sibpairs where at least one sib met the criteria.
Tumour localisation was classified according to the rules of
the Japanese Gastric Cancer Association24 with cancer
developing in the upper third of the stomach designated as
proximal gastric cancer and the rest as distal. Age at
diagnosis (younger than 50 years) was also considered for
subgroup stratification. Of the 170 affected sibpairs with
gastric cancer, 25 and 108 were classified into the proximal
and distal subgroups, respectively, 11 were included in both
subgroups, one did not met the criteria, and clear information
of tumour localisation was not obtained for 47 sibpairs.
Figure 1 Genome-wide scan for gastric cancer. Multipoint linkage analysis was carried out using 392 microsatellite markers for the entire set of
samples (170 sibpairs) using the MAPMAKER/SIBS program. The horizontal axis shows the distance from the p terminus (cM). Chr., chromosome.
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Regarding histological type, 76 and 62 sibpairs were classified
into diffuse and intestinal subgroups, respectively, 32 were
included in both subgroups, and clear histological informa-
tion was not obtained for 64 sibpairs. A total of 53 sibpairs
met the criteria that at diagnosis at least one sib was less than
50 years old.
RESULTS AND DISCUSSION
The entire set of 170 informative affected sibpairs with gastric
cancer was initially analysed. Figure 1 shows the multipoint
LOD scores for gastric cancer as a qualitative trait with
markers on all chromosomes, determined using the
MAPMAKER/SIBS program. Four chromosomal regions,
1p32, 2q33–2q35, 11p13–14, and 21q21, were identified as
providing nominal evidence for linkage with multipoint LOD
scores of >1.18, corresponding to p(0.01. The highest
multipoint LOD score was observed on chromosome 2q33
and 11p14 (both D2S325 and D11S904 showed an LOD of
1.74, p=0.002). Two point analysis revealed an additional
chromosomal region, 1q32, with an LOD score of >1.18
(D1S425, LOD=2.16). D2S325, D11S904, and D21S1256 had
LOD scores of >1.18 in multipoint and two point analyses.
The two point LOD score of D2S325 was higher than that of
D11S904 (1.98 and 1.37, respectively). None of the regions,
however, reached the threshold for suggestive (LOD=2.2,
p=0.0007) or significant (LOD=3.6, p=0.00002) evidence
for linkage.20
Gastric cancer has been classified into two subgroups
based on tumour localisation (cardia or non-cardia) and into
two histological subtypes (intestinal or diffuse). Most gastric
cancer develops in the distal portion of the stomach (non-
cardia) and a spontaneous decrease in the incidence of this
type has been observed in many populations, whereas the
incidence of cancer originating in the gastric cardia appears
to be relatively stable.22 25 26 The intestinal type seems to be
highly prevalent in populations with high rates of gastric
cancer. By contrast, the diffuse type is predominant in
populations with a low incidence of the disease.27 28 These
diverging trends in incidence imply different etiologies in
both subsites and histological subtypes of gastric cancer. In
order to examine if the weak linkage of gastric cancer with
the chromosomal regions observed in the entire data set
shows subsite or histological subtype specificity, linkage
analyses were carried out for stratified subgroups. Six
chromosomal regions exceeding a multipoint LOD score of
1.18 were found in an analysis of the proximal gastric cancer
subgroup (chromosomes 1p32–p33, 2q31–q36, 5q11–q12,
8p23, 19p13, and Xp11; table 1). In particular, the markers
on chromosome 2q31–q36 showed LOD scores .2.0, while
that of D2S325 (chromosome 2q33.3) was 3.61 (p,0.00002),








Multipoint data Two point data
LOD Point wise p LOD Point wise p
Proximal, Chromosome 1
n =25` D1S2797 77.6 1p33 73.8 1.66 0.0028 (0.90) 0.021
D1S2890 87.7 1p32.2 76.9 1.60 0.0033 (0.60) 0.048
Chromosome 2
D2S364 186.2 2q31.3 79.9 2.13 0.00086 1.21 0.0091
D2S117 194.5 2q32.3 89.2 2.02 0.0012 (1.10) 0.012
D2S325 210.9 2q33.3 74.5 3.61 0.00002 2.93 0.0001
D2S2382 220.7 2q35 51.1 2.59 0.00028 (0.57) 0.053
D2S126 220.1 2q36.1 76.7 2.11 0.00091 1.60 0.0033
Chromosome 5
D5S407 64.7 5q11.2 82.8 1.18 0.0098 (0.52) 0.061
D5S647 74.7 5q12.3 82.7 1.57 0.0036 2.16 0.0008
Chromosome 8
D8S277 8.3 8p23.1 83.2 1.78 0.0021 1.24 0.0083
Chromosome 19
D19S884 26.0 19p13.2 80.0 1.31 0.0071 1.21 0.0090
D19S220 61.4 19q13.13 90.7 (0.86) 0.023 2.22 0.0007
Chromosome X
DXS993 66.1 Xp11.4 74.5 1.21 0.0092 (0.25) 0.14
Distal, Chromosome 2
n =108 D2S162 20.0 2p25.1 78.1 (0.34) 0.11 1.46 0.0048
D2S325 204.5 2q33.3 74.5 1.41 0.0055 1.38 0.0059
Chromosome 11
D11S904 33.6 11p14.2 16.3 1.36 0.0061 1.65 0.0029
D11S935 49.6 11p13 75.5 (0.44) 0.077 1.67 0.0028
Diffuse, Chromosome 11
n =76 D11S904 33.6 11p14.2 16.3 2.12 0.0009 1.57 0.0035
D11S935 45.9 11p13 75.5 1.45 0.0049 3.51 0.00003
D11S1314 73.6 11q13.4 74.6 (0.81) 0.027 1.37 0.0060
Intestinal, Chromosome 21
n =62 D21S1256 8.6 21q21.1 63.5 1.35 0.0064 (1.16) 0.01
D21S1914 19.4 21q21.2 87.7 1.23 0.0087 (1.07) 0.013
Age at Chromosome 2
diagnosis D2S325 204.5 2q33.3 74.5 1.96 0.0013 (1.08) 0.013
,50, D2S2382 220.7 2q35 51.1 1.59 0.0034 (0.51) 0.063
n =53 Chromosome 21
D21S1256 8.6 21q21.1 63.5 1.34 0.0066 1.31 0.0070
*Marker positions are from the database of a GenethonMap in the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov/).
Entries with an LOD score of ,1.18 are in parentheses.
`Number of sibpairs analysed.
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which was beyond the strict level for genome-wide statistical
significance.20 This marker showed an LOD score of 2.93
(p=0.0001) in a two point analysis. Simulation studies using
the MERLIN program for the proximal subgroup revealed
that only two replicates demonstrated multipoint LOD scores
of .3.6 for D2S325 among 1000 replicates of simulation,
suggesting a genetic link between the proximal subgroup and
this marker. To further confirm this finding, an additional
seven markers covering 50 cM of chromosome 2q31–q36
were typed and reanalysis including the initial markers on
this region was carried out (fig 2). This additional mapping
revealed that the LOD scores for 2q33–q35 were greater than
2.2, confirming evidence suggestive of linkage.20 The stron-
gest linkage signal was obtained for D2S325 with an LOD
score of 3.37. The MERLIN program, which calculates the
LOD score using the Kong and Cox d method under an
exponential model, was applied to region 2q33–q35 for
additional information. It was found that D2S325 showed a
multipoint LOD score of 2.66 (p=0.0002) (fig 2, dotted line).
Thus, even though the sample size was small, 2q33–q35 was
suggested to be a gastric cancer susceptibility locus, especially
for tumours localised in the proximal region of the stomach.
On the other hand, two chromosomal regions, 2q33 and
11p14, showed weak linkage in an analysis of the distal
gastric cancer subgroup (table 1).
When histological subgroups were analysed, 11p13–14 and
21q21 showed linkage in the diffuse and intestinal sub-
groups, respectively (table 1). In particular, markers D11S904
and D11S935 on 11p13–p14 showed moderate linkage signals
in multipoint and two point analyses in the diffuse type
(multipoint LOD=2.12 and 1.45, two point LOD=1.57 and
3.51, respectively). The etiology of the diffuse type of gastric
cancer is presumed to be less affected by environmental
factors than the intestinal type. A study reporting association
of the CDH1 germline mutations with the development of the
diffuse type provided the first evidence that gastric cancer
had a molecular basis in predisposed families.12 Our data
suggest that genetic polymorphism in other genes on
chromosome 11p13–p14 may be responsible for tumourigen-
esis of the diffuse type of gastric cancer. We also analysed a
subgroup of sibpairs with age at diagnosis younger than
50 years old. Even though the LOD scores were not high, two
linkage signals were detected on chromosome 2q33–q35 and
21q21 which also showed nominal evidence for linkage in an
analysis of the entire data set (table 1).
Gastric cancer is a complex disease, and there are different
etiologies, including environmental and genetic factors, for
the different types. Previous studies indicate that gastric
cardia cancer is less influenced by H. pylori infection, the
main environmental risk factor, than non-cardia cancer.29–31
As the incidence of cardia cancer is reported to be stable, it
may be that hereditary components have important roles in
the tumourigenesis of this type of gastric cancer. Lagergren
and co-workers reported that the risk of cardia cancer was
moderately increased among persons with first degree
relatives with gastric cancer in a nationwide case-control
study in Sweden.32 This finding also supports a genetic link
with cardia cancer. In this present study, we found that
chromosome 2q33–q35 is a potential susceptibility locus for
proximal gastric cancer. Data on the genome-wide scan
presented here may contribute to a better understanding of
genetic factors related to gastric cancer, particularly cardia
cancer, although larger samples and additional ethnic
populations will be needed.
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